Novartis (NVS) said to weight selling ritalin, clozaril, exelon drugs - Bloomberg

November 22, 2016 6:58 AM EST

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Novartis (NYSE: NVS) said to weight selling ritalin, clozaril, exelon drugs, according to Bloomberg headlines. The drugs could bring in over $300 million for the company.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors, Spinoffs, Trader Talk

Add Your Comment